Capstone Therapeutics Corp
OTC:CAPS

Watchlist Manager
Capstone Therapeutics Corp Logo
Capstone Therapeutics Corp
OTC:CAPS
Watchlist
Price: 0.76 USD 1.33% Market Closed
Market Cap: 6.3m USD

Wall Street
Price Targets

CAPS Price Targets Summary
Capstone Therapeutics Corp

Wall Street analysts forecast CAPS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
697% Upside
Average
Price Target
6.12 USD
705% Upside
Highest
Price Target
6.3 USD
729% Upside
Capstone Therapeutics Corp Competitors:
Price Targets
688235
Beigene Ltd
33% Upside
IMTX
Immatics NV
85% Upside
7774
Japan Tissue Engineering Co Ltd
150% Upside
688363
Bloomage Biotechnology Corp Ltd
9% Upside
ANAB
AnaptysBio Inc
16% Upside
1530
3SBio Inc
49% Upside
RNA
Avidity Biosciences Inc
3% Upside
KMDA
Kamada Ltd
87% Upside

Revenue
Forecast

Revenue Estimate
Capstone Therapeutics Corp

Revenue forecast
is not available for
Capstone Therapeutics Corp

Operating Income
Forecast

Operating Income Estimate
Capstone Therapeutics Corp

Operating Income forecast
is not available for
Capstone Therapeutics Corp

Net Income
Forecast

Net Income Estimate
Capstone Therapeutics Corp

Net Income forecast
is not available for
Capstone Therapeutics Corp
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPS's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CAPS is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top